DE69940859D1 - Expression von rekombinantem, reifem lysostaphin - Google Patents
Expression von rekombinantem, reifem lysostaphinInfo
- Publication number
- DE69940859D1 DE69940859D1 DE69940859T DE69940859T DE69940859D1 DE 69940859 D1 DE69940859 D1 DE 69940859D1 DE 69940859 T DE69940859 T DE 69940859T DE 69940859 T DE69940859 T DE 69940859T DE 69940859 D1 DE69940859 D1 DE 69940859D1
- Authority
- DE
- Germany
- Prior art keywords
- lysostaphin
- preprolysostaphin
- prolysostaphin
- mature
- ripe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB1999/001704 WO2001029201A1 (en) | 1999-10-19 | 1999-10-19 | Expression of recombinant mature lysostaphin |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69940859D1 true DE69940859D1 (de) | 2009-06-18 |
Family
ID=11004914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69940859T Expired - Lifetime DE69940859D1 (de) | 1999-10-19 | 1999-10-19 | Expression von rekombinantem, reifem lysostaphin |
Country Status (13)
Country | Link |
---|---|
US (1) | US6897041B1 (de) |
EP (1) | EP1224271B1 (de) |
JP (1) | JP2003512050A (de) |
KR (1) | KR100635426B1 (de) |
CN (1) | CN1267551C (de) |
AT (1) | ATE430799T1 (de) |
AU (1) | AU784354B2 (de) |
BR (1) | BR9917526B1 (de) |
CA (1) | CA2388003C (de) |
DE (1) | DE69940859D1 (de) |
MX (1) | MXPA02003885A (de) |
NZ (1) | NZ518963A (de) |
WO (1) | WO2001029201A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1465990B1 (de) * | 2001-12-21 | 2011-07-13 | Biosynexus Incorporated | Gestutzes lysostaphin-molekül mit verbesserter staphylolytischer wirkung |
CN100475965C (zh) * | 2005-07-22 | 2009-04-08 | 上海高科联合生物技术研发有限公司 | 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法 |
WO2008105826A2 (en) * | 2006-09-05 | 2008-09-04 | Biosynexus Incorporated | Compositions compromising lysostaphin variants and methods of using the same |
AU2008273946A1 (en) * | 2007-07-09 | 2009-01-15 | Microsens Medtech Limited | Detection of micro-organisms based on their NAD-dependent DNA ligase activity |
US20110044968A1 (en) * | 2008-03-10 | 2011-02-24 | Pharmal N Corporation | Compositions for treatment with metallopeptidases, methods of making and using the same |
US8821860B2 (en) * | 2009-08-07 | 2014-09-02 | Lawrence Livermore National Security, Llc | Targeted antimicrobials and related compositions, methods and systems |
CN105579053B (zh) | 2013-08-06 | 2021-08-31 | 达特茅斯学院理事会 | 非糖基化溶葡球菌素变体蛋白 |
US9814766B2 (en) | 2013-12-28 | 2017-11-14 | Longhorn Vaccines And Diagnostics, Llc | Multimodal antimicrobial therapy |
KR102195998B1 (ko) * | 2019-09-27 | 2020-12-29 | 코스맥스 주식회사 | 스타필로코커스 시뮬란스 st-9 균주 및 그의 피부 상태 개선 용도 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5079159A (en) * | 1983-12-27 | 1992-01-07 | Genetics Institute, Inc. | Method for making tissue plasminogen activator |
US4931390A (en) * | 1986-04-16 | 1990-06-05 | Public Health Research Institute Of The City Of New York, Inc. | Expression of the cloned lysostaphin gene |
JPH0811074B2 (ja) | 1987-10-30 | 1996-02-07 | 財団法人化学及血清療法研究所 | プレアルブミンをコードする遺伝子を組込んだ組換えプラスミドおよびこれを用いたプレアルブミンの製法 |
US5122457A (en) * | 1989-10-19 | 1992-06-16 | Schering Corporation | Expression systems utilizing bacteriophage t7 promoters, gene sequences, and t7 rna polymerase |
US5530100A (en) * | 1990-05-07 | 1996-06-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Methods for purification of recombinantly produced proteins |
JP2552942B2 (ja) | 1990-06-01 | 1996-11-13 | 三井東圧化学株式会社 | ヒトbーFGF受容体遺伝子 |
US5824528A (en) * | 1992-05-01 | 1998-10-20 | Associated Universities, Inc. | Cloning and expression of autogenes encoding RNA poly,erases of T7-like bacteriophages |
NZ254684A (en) * | 1992-08-14 | 1997-01-29 | Commw Scient Ind Res Org | Small rna heliothis armigera stunt virus (hasv), related mutants and variants and their use in controlling insect pests |
DE4425645A1 (de) * | 1994-07-20 | 1996-02-22 | Mueller Karl & Co Kg | Deletiertes Lysostaphingen von Staphylococcus simulans |
FR2724665B1 (fr) * | 1994-09-16 | 1996-12-20 | Rhone Poulenc Rorer Sa | Procede de production de proteines recombinantes, plasmides et cellules modifiees |
IL118473A0 (en) * | 1995-06-02 | 1996-09-12 | Suntory Ltd | Staphylococcus aureus V8 protease genes coding therefor and a method for the production thereof |
GB9614700D0 (en) * | 1996-07-12 | 1996-09-04 | Medical Res Council | Over-expression of proteins in E.Coli |
CA2211293A1 (en) | 1997-07-23 | 1999-01-23 | Immunova Ltee | Recombinant lysostaphin analogs |
-
1999
- 1999-10-19 CN CNB998170496A patent/CN1267551C/zh not_active Expired - Fee Related
- 1999-10-19 EP EP99974124A patent/EP1224271B1/de not_active Expired - Lifetime
- 1999-10-19 US US10/110,795 patent/US6897041B1/en not_active Expired - Lifetime
- 1999-10-19 MX MXPA02003885A patent/MXPA02003885A/es not_active IP Right Cessation
- 1999-10-19 NZ NZ518963A patent/NZ518963A/xx not_active IP Right Cessation
- 1999-10-19 BR BRPI9917526-6B1A patent/BR9917526B1/pt not_active IP Right Cessation
- 1999-10-19 KR KR1020027004972A patent/KR100635426B1/ko not_active IP Right Cessation
- 1999-10-19 WO PCT/IB1999/001704 patent/WO2001029201A1/en active IP Right Grant
- 1999-10-19 AU AU59955/99A patent/AU784354B2/en not_active Ceased
- 1999-10-19 AT AT99974124T patent/ATE430799T1/de not_active IP Right Cessation
- 1999-10-19 DE DE69940859T patent/DE69940859D1/de not_active Expired - Lifetime
- 1999-10-19 CA CA2388003A patent/CA2388003C/en not_active Expired - Fee Related
- 1999-10-19 JP JP2001532186A patent/JP2003512050A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU5995599A (en) | 2001-04-30 |
CA2388003A1 (en) | 2001-04-26 |
KR20020064886A (ko) | 2002-08-10 |
JP2003512050A (ja) | 2003-04-02 |
AU784354B2 (en) | 2006-03-16 |
EP1224271A4 (de) | 2002-11-27 |
BR9917526B1 (pt) | 2013-09-24 |
BR9917526A (pt) | 2002-06-11 |
ATE430799T1 (de) | 2009-05-15 |
WO2001029201A1 (en) | 2001-04-26 |
NZ518963A (en) | 2002-11-26 |
EP1224271A1 (de) | 2002-07-24 |
CA2388003C (en) | 2013-02-19 |
CN1267551C (zh) | 2006-08-02 |
KR100635426B1 (ko) | 2006-10-18 |
EP1224271B1 (de) | 2009-05-06 |
MXPA02003885A (es) | 2005-06-03 |
CN1406278A (zh) | 2003-03-26 |
US6897041B1 (en) | 2005-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69940859D1 (de) | Expression von rekombinantem, reifem lysostaphin | |
EP0797436A4 (de) | Neuartige adenovirale vektoren, verpackungsszellinien, rekombinante adenoviren und verfahren | |
WO2002046412A3 (en) | Regulation of angiogenesis with zinc finger proteins | |
DK172276A (da) | Pulshastighedsindikator | |
DK0605501T5 (da) | Anvendelse af præsynaptisk neurotoksin til behandling af cerebel parese | |
WO2001087958A3 (en) | CRYSTAL STRUCTURE OF WORM NitFhit REVEALS THAT A Nit TETRAMER BINDS TWO Fhit DIMERS | |
NO990086D0 (no) | Avkortete, oppl÷selige tumornekrosefaktorreseptorer av type I og type II | |
NO972373D0 (no) | Vektorer for vevs-spesifikk replikasjon | |
CY1109648T1 (el) | Μη νευροτοξικοι παραγοντες ενεργοποιησης πλασμινογονου για την αγωγη εγκεφαλικου επεισοδιου | |
ATE314475T1 (de) | Rekombinantes pseudomonas exotoxin mit gesteigerter aktivität | |
DE69838676D1 (de) | Neuartige phytase | |
DK0933995T3 (da) | Fremgangsmåde til behandling af endotelskader | |
GR3036686T3 (en) | Therapeutic uses of bactericidal/permeability increasing protein products | |
NZ513349A (en) | Polypeptides involved in immune response | |
WO2002024930A3 (en) | Artificial ubiquitous chromatin opening elements (ucoe) | |
ATE529441T1 (de) | Expression von proteinen in e.coli | |
DK2272951T3 (da) | VKORC1 (vitamin-K-epoxid-tilbageførings-polypeptid), et terapeutisk mål for coumarin og derivater deraf | |
BR0017157A (pt) | Derivados de 6-hidroxi-indazol para o tratamento de glaucoma | |
ATE199168T1 (de) | Stabilisierung von plasmiden | |
YU59604A (sh) | Fibrinolitički aktivan polipeptid | |
DE69838681D1 (de) | Escherichia coli hochexpressionsvektor | |
DE60101486D1 (de) | Verwendung von Polyaminosäurederivate als Konservierungsmittel | |
IL90334A0 (en) | Genetic transformation of b.thuringiensis,vectors used therefor,host cells transformed by the vectors and use of said cells as insecticides | |
NO995959L (no) | DNA-sekvens, vektor, transformerte eukaryote eller prokaryote vertsceller, fremgangsmater for fremstilling av et protein, polypeptid, antistoff, fremgangsmate for isolering og identifisering, farmasoytisk sammensetning og fremgangsmate for screening. | |
GB0022995D0 (en) | Polynucleotide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1224271 Country of ref document: EP Representative=s name: DR. MEYER-DULHEUER & PARTNER, DE |